about
The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification systemPrediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosisNrf2 expression in endometrial serous carcinomas and its precancers.My approach to the interpretation of endometrial biopsies and curettings.Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformationDoes the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases.Endometrial biopsy: a karyometric and stereological study.Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.Endometrial intraepithelial neoplasia is associated with polyps and frequently has metaplastic change.Squamous morules are functionally inert elements of premalignant endometrial neoplasia.The endometrial hyperplasias revisited.Angiogenesis in pre-malignant conditionsAltered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium.Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma.Quantification of differences in the effective atomic numbers of healthy and cancerous tissues: a discussion in the context of diagnostics and dosimetry.Automatic measurement of volume percentage stroma in endometrial images using texture segmentation.Bariatric surgery and endometrial pathology in asymptomatic morbidly obese women: a prospective, pilot study.EIN and WHO94.BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia.Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists.Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger.
P2860
Q24646398-BD323102-48F8-4482-9FEE-9388BE158AAAQ24647890-A96B5012-4F52-4420-A84E-F2CFD09EB9DCQ34467239-7E4903BD-FC66-40B6-831A-45438FF4CBBFQ35770233-2E2D3506-8B27-41CF-80DB-E2BBA4F3EAFBQ36174374-F24B624E-0642-4E13-A4A1-272D50131F06Q36493879-F4C9F182-7A0B-4B80-A48D-253C537F5280Q36530267-7C76241A-A1A8-4087-A601-6FD86E9E3E86Q36608842-E9166EBE-4714-48CD-B851-7C99301D9ED3Q36952350-2F575645-68F1-4B62-9000-A5A623CF220AQ37078918-991C18D4-D585-4253-9F66-92D36F0B2ED8Q37251777-FFE5AD50-9CF6-4C4B-BD78-A18E0B773392Q37305411-C26BC69A-F062-40A2-80FB-3A348D69CF23Q37460521-6FD97803-4F13-4197-9CB5-3559EDF5FE72Q38844574-16831151-950F-49BC-A876-2E573BCC3CB5Q39556716-6970E250-D030-4211-90C6-C81DE6E43BA4Q39960771-D1D0A593-23A9-4ED2-8732-0A730E82B370Q40079686-1D63EFE9-6A93-4DB5-A870-7DE5434C987FQ43010392-E3EC351B-6538-4A08-AF56-BAD4AAF2CA55Q47261979-D1A7E64C-C9BD-43D1-AD9F-DCAFC85AB882Q53095157-03AC8DFD-75D5-4E58-ADE3-39D8A015939BQ53174208-52B8E116-BB53-4FA3-B5A6-012AAD87A19D
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Diagnosis of premalignant endometrial disease.
@ast
Diagnosis of premalignant endometrial disease.
@en
type
label
Diagnosis of premalignant endometrial disease.
@ast
Diagnosis of premalignant endometrial disease.
@en
prefLabel
Diagnosis of premalignant endometrial disease.
@ast
Diagnosis of premalignant endometrial disease.
@en
P2860
P356
P1476
Diagnosis of premalignant endometrial disease.
@en
P2093
G L Mutter
P2860
P304
P356
10.1136/JCP.55.5.326
P407
P577
2002-05-01T00:00:00Z